SCHEMBL6356779

SCHEMBL6356779

CCCS(=O)(=O)NC1CCCCC1(O)c1ccc(OCCN)cc1

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
TSHR P16473 1/20 0.39
LMNA P02545 3/20 0.36
ALDH1A1 P00352 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ITGB3 P05106 2/20 0.35
ITGA2B P08514 2/20 0.35
CYP3A4 P08684 1/20 0.34
SLC6A9 P48067 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C19 P33261 1/20 0.34
GAA P10253 1/20 0.34
ENPP3 O14638 1/20 0.33
ENPP1 P22413 1/20 0.33
ENPP2 Q13822 1/20 0.33
SLC6A5 Q9Y345 1/20 0.32
SPHK1 Q9NYA1 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6345333 0.97 MEN1 (0.37) MEN1KMT2ATSHRLMNAALDH1A1
SCHEMBL6349725 0.89 SLC6A9 (0.44) MEN1KMT2ATSHRLMNAALDH1A1
SCHEMBL6344428 0.87 ALDH1A1 (0.42) MEN1KMT2ATSHRLMNAALDH1A1
SCHEMBL6345791 0.86 ALDH1A1 (0.44) MEN1KMT2ATSHRALDH1A1L3MBTL1
SCHEMBL6244914 0.86 SLC6A4 (0.42) MEN1KMT2ASLC6A9SLC6A5
SCHEMBL6348954 0.86 SLC6A9 (0.45) MEN1KMT2ATSHRLMNAALDH1A1
SCHEMBL6355076 0.85 MEN1 (0.34) MEN1KMT2ATSHRLMNAALDH1A1
SCHEMBL6356775 0.84 ALDH1A1 (0.36) MEN1KMT2ATSHRLMNAALDH1A1
SCHEMBL6345481 0.84 ALDH1A1 (0.42) MEN1KMT2ATSHRLMNAALDH1A1
SCHEMBL6348256 0.84 AR (0.44) KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900353-B2 Cyclopentyl sulfonamide derivatives ELI LILLY AND COMPANY (US) 2005-05-31 US disclosed
US-20040067984-A1 Cyclopentyl sulfonamide derivatives CANTRELL BUDDY EUGENE (US) 2004-04-08 US disclosed
EP-1334087-A1 CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2003-08-13 EP disclosed
WO-2002032858-A1 CYCLOALKYLFLUOROSULFONAMIDE DERIVATIVES ELI LILLY AND COMPANY (US) 2002-04-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040067984-A1 Cyclopentyl sulfonamide derivatives GRIN2A, GRIN1, GRIK5 MEN1 4591/4885KMT2A 2076/4885TSHR 563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.